426 related articles for article (PubMed ID: 27799210)
1. Screening and Characterization of a Non-cyp51A Mutation in an Aspergillus fumigatus cox10 Strain Conferring Azole Resistance.
Wei X; Chen P; Gao R; Li Y; Zhang A; Liu F; Lu L
Antimicrob Agents Chemother; 2017 Jan; 61(1):. PubMed ID: 27799210
[TBL] [Abstract][Full Text] [Related]
2. Genomic perspective of triazole resistance in clinical and environmental Aspergillus fumigatus isolates without cyp51A mutations.
Sharma C; Nelson-Sathi S; Singh A; Radhakrishna Pillai M; Chowdhary A
Fungal Genet Biol; 2019 Nov; 132():103265. PubMed ID: 31465846
[TBL] [Abstract][Full Text] [Related]
3. The cdr1B efflux transporter is associated with non-cyp51a-mediated itraconazole resistance in Aspergillus fumigatus.
Fraczek MG; Bromley M; Buied A; Moore CB; Rajendran R; Rautemaa R; Ramage G; Denning DW; Bowyer P
J Antimicrob Chemother; 2013 Jul; 68(7):1486-96. PubMed ID: 23580559
[TBL] [Abstract][Full Text] [Related]
4. Quantitative Analysis of Single-Nucleotide Polymorphism for Rapid Detection of TR34/L98H- and TR46/Y121F/T289A-Positive Aspergillus fumigatus Isolates Obtained from Patients in Iran from 2010 to 2014.
Mohammadi F; Hashemi SJ; Zoll J; Melchers WJ; Rafati H; Dehghan P; Rezaie S; Tolooe A; Tamadon Y; van der Lee HA; Verweij PE; Seyedmousavi S
Antimicrob Agents Chemother; 2016 Jan; 60(1):387-92. PubMed ID: 26525787
[TBL] [Abstract][Full Text] [Related]
5. cyp51A gene silencing using RNA interference in azole-resistant Aspergillus fumigatus.
Mousavi B; Hedayati MT; Teimoori-Toolabi L; Guillot J; Alizadeh A; Badali H
Mycoses; 2015 Dec; 58(12):699-706. PubMed ID: 26448519
[TBL] [Abstract][Full Text] [Related]
6. In Vitro Activity of ASP2397 against Aspergillus Isolates with or without Acquired Azole Resistance Mechanisms.
Arendrup MC; Jensen RH; Cuenca-Estrella M
Antimicrob Agents Chemother; 2016 Jan; 60(1):532-6. PubMed ID: 26552973
[TBL] [Abstract][Full Text] [Related]
7. Insight into the Significance of Aspergillus fumigatus cyp51A Polymorphisms.
Garcia-Rubio R; Alcazar-Fuoli L; Monteiro MC; Monzon S; Cuesta I; Pelaez T; Mellado E
Antimicrob Agents Chemother; 2018 Jun; 62(6):. PubMed ID: 29632011
[TBL] [Abstract][Full Text] [Related]
8. Multiple cyp51A-based mechanisms identified in azole-resistant isolates of Aspergillus fumigatus from China.
Liu M; Zeng R; Zhang L; Li D; Lv G; Shen Y; Zheng H; Zhang Q; Zhao J; Zheng N; Liu W
Antimicrob Agents Chemother; 2015 Jul; 59(7):4321-5. PubMed ID: 25896700
[TBL] [Abstract][Full Text] [Related]
9. Contributions of both ATP-Binding Cassette Transporter and Cyp51A Proteins Are Essential for Azole Resistance in Aspergillus fumigatus.
Paul S; Diekema D; Moye-Rowley WS
Antimicrob Agents Chemother; 2017 May; 61(5):. PubMed ID: 28264842
[TBL] [Abstract][Full Text] [Related]
10. Genotype-phenotype complexity of the TR46/Y121F/T289A cyp51A azole resistance mechanism in Aspergillus fumigatus.
Snelders E; Camps SM; Karawajczyk A; Rijs AJ; Zoll J; Verweij PE; Melchers WJ
Fungal Genet Biol; 2015 Sep; 82():129-35. PubMed ID: 26092193
[TBL] [Abstract][Full Text] [Related]
11. Non-cyp51A Azole-Resistant Aspergillus fumigatus Isolates with Mutation in HMG-CoA Reductase.
Hagiwara D; Arai T; Takahashi H; Kusuya Y; Watanabe A; Kamei K
Emerg Infect Dis; 2018 Oct; 24(10):1889-1897. PubMed ID: 30226177
[TBL] [Abstract][Full Text] [Related]
12. cyp51A-Based mechanisms of Aspergillus fumigatus azole drug resistance present in clinical samples from Germany.
Bader O; Weig M; Reichard U; Lugert R; Kuhns M; Christner M; Held J; Peter S; Schumacher U; Buchheidt D; Tintelnot K; Groß U;
Antimicrob Agents Chemother; 2013 Aug; 57(8):3513-7. PubMed ID: 23669382
[TBL] [Abstract][Full Text] [Related]
13. First determination of azole resistance in Aspergillus fumigatus strains carrying the TR34/L98H mutations in Turkey.
Özmerdiven GE; Ak S; Ener B; Ağca H; Cilo BD; Tunca B; Akalın H
J Infect Chemother; 2015 Aug; 21(8):581-6. PubMed ID: 26048062
[TBL] [Abstract][Full Text] [Related]
14. Surveillance for azole resistance in clinical and environmental isolates of Aspergillus fumigatus in Australia and cyp51A homology modelling of azole-resistant isolates.
Talbot JJ; Subedi S; Halliday CL; Hibbs DE; Lai F; Lopez-Ruiz FJ; Harper L; Park RF; Cuddy WS; Biswas C; Cooley L; Carter D; Sorrell TC; Barrs VR; Chen SC
J Antimicrob Chemother; 2018 Sep; 73(9):2347-2351. PubMed ID: 29846581
[TBL] [Abstract][Full Text] [Related]
15. cyp51A-based mechanism of azole resistance in Aspergillus fumigatus: Illustration by a new 3D Structural Model of Aspergillus fumigatus CYP51A protein.
Liu M; Zheng N; Li D; Zheng H; Zhang L; Ge H; Liu W
Med Mycol; 2016 May; 54(4):400-8. PubMed ID: 26768370
[TBL] [Abstract][Full Text] [Related]
16. A new Aspergillus fumigatus resistance mechanism conferring in vitro cross-resistance to azole antifungals involves a combination of cyp51A alterations.
Mellado E; Garcia-Effron G; Alcázar-Fuoli L; Melchers WJ; Verweij PE; Cuenca-Estrella M; Rodríguez-Tudela JL
Antimicrob Agents Chemother; 2007 Jun; 51(6):1897-904. PubMed ID: 17371828
[TBL] [Abstract][Full Text] [Related]
17. Azole Resistance of Environmental and Clinical Aspergillus fumigatus Isolates from Switzerland.
Riat A; Plojoux J; Gindro K; Schrenzel J; Sanglard D
Antimicrob Agents Chemother; 2018 Apr; 62(4):. PubMed ID: 29437612
[No Abstract] [Full Text] [Related]
18. Azole resistance and cyp51A mutation screening in Aspergillus fumigatus in Mexico.
Gonzalez-Lara MF; Roman-Montes CM; Diaz-Lomeli P; Rangel-Cordero A; Valenzuela MO; Ponce-de-Leon A; Sifuentes-Osornio J; Ostrosky-Zeichner L; Martinez-Gamboa A
J Antimicrob Chemother; 2019 Jul; 74(7):2047-2050. PubMed ID: 31220262
[TBL] [Abstract][Full Text] [Related]
19.
Talbot JJ; Frisvad JC; Meis JF; Hagen F; Verweij PE; Hibbs DE; Lai F; Groundwater PW; Samson RA; Kidd SE; Barrs VR; Houbraken J
Antimicrob Agents Chemother; 2019 Nov; 63(11):. PubMed ID: 31451501
[TBL] [Abstract][Full Text] [Related]
20. A Novel Zn2-Cys6 Transcription Factor AtrR Plays a Key Role in an Azole Resistance Mechanism of Aspergillus fumigatus by Co-regulating cyp51A and cdr1B Expressions.
Hagiwara D; Miura D; Shimizu K; Paul S; Ohba A; Gonoi T; Watanabe A; Kamei K; Shintani T; Moye-Rowley WS; Kawamoto S; Gomi K
PLoS Pathog; 2017 Jan; 13(1):e1006096. PubMed ID: 28052140
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]